Abel Pharmboy shows why I shouldn't have left my American Society of Clinical Oncology (ASCO) proceedings abstract sit on my desk unread for a week.
Damn. Talk about blowing an opportunity. Of course, given that I don't own any pharmaceutical stocks (making me a rather poor "tool of big pharma" indeed), it doesn't matter.
More like this
It's nearing the beginning of June, the traditional time for increased stock trading based on results presented at the American Society of Clinical Oncology (ASCO) annual meeting (1-5 June in Chicago). The meeting is often the first time that the general public learns of the progress of cancer…
Well, I'm home.
As I've mentioned before, I attended the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Although one of the problems with ASCO, at least for surgeons like me, is that it is a meeting completely dominated by medical oncology. Quite frankly, not that…
I didn't think I'd be discussing Dr. David Katz again so soon after the last time. In fact, when blog bud Mark Crislip (who clearly hates me and wants me to pop an aneurysm or have a heart attack, given how often he sends me links to articles as infuriating as this) sent me a link to Dr. Katz's…
As if yesterday's post weren't depressing enough, last weekend I attended the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago, which is part of the reason I didn't produce much in the way of posts about a week ago. Last Sunday, while aimlessly wandering from…
Since most of them went down it doesn't appear to be such a good prognosticator for cancer patients. If one knew much about which trials are done and ready to be reported on just knowing who went up and who went down would be a clue.
But Pharmboy has a point about insider information. Let's lock them all up like Martha Stewart!
At one point in my less than stellar investment experience I had hope that owning big pharm would help me afford their wares in my old age! These days I can only hope that some suffering factory worked in Southeast Asia will be my salvation.